Connect
← Return to Endometerial cancer with essential throbocythemia (ET) Jak 2 mutation
Discussion
Endometerial cancer with essential throbocythemia (ET) Jak 2 mutation
Gynecologic Cancers | Last Active: Oct 23, 2025 | Replies (20)Comment receiving replies
I'm not doing well. I have been on four different treatments this year, none of which have worked. I'm pretty sure one did significant harm and made the cancer grow faster. I'm about to switch again in a couple weeks, but I've reached the dregs of the standard of care options. There's a clinical trial I would like to try, but there won't be any slots open until they get something through the FDA, which is, of course, closed.
Replies to "@naturegirl5 I'm not doing well. I have been on four different treatments this year, none of..."
Connect
@val64 With all that you have going on with your own health I'm heartened to see you back here so regularly. You are a strong support with your knowledge and information. I wish you the same support that you so kindly offer others. The FDA. Closed at present in the U.S. affects the progress of clinical trials.
I hope that you are able to nurture yourself and that your friends and family are present for you. @val64, I feel my words are not enough to let you know how I wish for you to have every avenue open for your treatment and care.